Emergent BioSolutions (EBS) Insider Trading & Ownership

$1.98
-0.20 (-9.17%)
(As of 03:21 PM ET)

Emergent BioSolutions (NYSE:EBS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$29,526.50
Get EBS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Emergent BioSolutions stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

EBS Insider Buying and Selling by Quarter

Emergent BioSolutions Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/2/2023Kathryn C ZoonDirectorSell1,830$8.35$15,280.50  
5/25/2023Kathryn C ZoonDirectorSell1,700$8.38$14,246.00  
(Data available from 1/1/2013 forward)

EBS Insider Trading Activity - Frequently Asked Questions

Who is on Emergent BioSolutions's Insider Roster?

The list of insiders at Emergent BioSolutions includes Kathryn C Zoon, Richard S Lindahl, and Ronald Richard. Learn more on insiders at EBS.

What percentage of Emergent BioSolutions stock is owned by insiders?

1.20% of Emergent BioSolutions stock is owned by insiders. Learn more on EBS's insider holdings.

Which Emergent BioSolutions insiders have been selling company stock?

The following insiders have sold EBS shares in the last 24 months: Kathryn C Zoon ($137,417.34), and Ronald Richard ($22,829.28).

How much insider selling is happening at Emergent BioSolutions?

Insiders have sold a total of 8,611 Emergent BioSolutions shares in the last 24 months for a total of $160,246.62 sold.


More Insider Trading Tools from MarketBeat

This page (NYSE:EBS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners